Saturday, February 20, 2021 12:54:51 PM
I copy and paste it to all my colleagues and practitioners at the university teaching hospital here.As a medical anthropologist I am not on the frontline bút do advise and counsel front line intensive care personell, general practitioners, researchers and maybe most useful the designers of the hygenic concepts and intensiv care environments .
It is amazing that AVIPTADIL has been used in it's inhalation form here at the university hospital for pneumonia resulting from intensive chemotherapy with great success for years as published in the NEJM but the ICU 2 blocks down from the oncology campus is not aware of its use at all.
Sometimes I feel more like an evangelist than anything else with an endless effort to overcome the conditioned reflex of doubting anything that appears to be positive ...
Also the company ADVITA which RLF is going to buy up with shares only is domiciled here and has been supplying these clinical trials with inhalation devices
FYI
https://www.uniklinik-freiburg.de/presse/pressemitteilungen/detailansicht/2058-hormon-inhalation-stoppt-schwere-nebenwirkung-von-immun-krebstherapie.html
Original-Titel der Publikation:
Vasoactive Intestinal Peptide in Checkpoint Inhibitor–Induced Pneumonitis
DOI: 10.1056/NEJMc2000343
Link zur Studie:https://www.nejm.org/doi/10.1056/NEJMc2000343
Kontakt:
Prof. Dr. Joachim Müller-Quernheim
Ärztlicher Direktor
Klinik für Pneumologie
Universitätsklinikum Freiburg
Telefon: 0761 270-37060
joachim.mueller-quernheim@uniklinik-freiburg.de
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM